NASCAR Star Jeff Gordon’s Healthy Life on and off the Track
What drives this champion to win on the racetrack, as a husband and a dad, and in his quest to help kids with life-threatening conditions?
The Jeff Gordon Foundation continued...
His foundation’s work is not limited to treating the illnesses themselves. It also seeks ways to improve quality of life for sick children and their families. For Gordon, no race weekend is complete unless he grants at least one child’s wish to meet him. He has made 200 such wishes come true during his career.
One of the many benefactors of The Jeff Gordon Foundation is the National Marrow Donor Program, based in Minneapolis. An estimated 10,000 people a year are stricken with diseases for which bone marrow transplants are the only cure. Most suffer from forms of leukemia or lymphoma, but more than 70 different diseases are treated with marrow transplants. The NMDP connects patients with donors and doctors, as well as supporting them during treatment and through the lengthy recuperation period.
“We are asked to participate when there is no other cure,” says NMDP Director Jeffrey Chell, MD. According to Chell, only 25% of those needing transplants find a match within their immediate family. Most have to depend on strangers. That’s where the NMDP fits in. One of its priorities is recruiting donors for a marrow registry. When a person donates marrow, a hollow needle is used to withdraw liquid marrow from the pelvic bone. Soreness in the lower back, discomfort while walking, and tiredness are the most common aftereffects, and they normally last a few days. The body generally takes four to six weeks to replace the donated marrow.
Gordon himself has registered with the NMDP. “Jeff’s DNA is in the registry, and he could be called on at any time to be a donor,” Kriger says. “In fact, he has gotten all of us on the foundation staff to register as donors. Actually, it was a pretty easy thing to do when you meet some of these kids.”
The foundation, which turns 10 next year, is already planning its strategy for its second decade. Its core mission of providing funds to the nation’s most prominent centers for pediatric research and care will remain the same, and, says Kriger, Gordon will likely become even more involved. Chell agrees: “He understands the complexities of the problems and communicates them so well to a broad spectrum of people. He’s gone to Capitol Hill and served as an advocate there, helping members of Congress understand the scope of the issue.”